Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2232434rdf:typepubmed:Citationlld:pubmed
pubmed-article:2232434lifeskim:mentionsumls-concept:C0559546lld:lifeskim
pubmed-article:2232434lifeskim:mentionsumls-concept:C0450442lld:lifeskim
pubmed-article:2232434lifeskim:mentionsumls-concept:C0332162lld:lifeskim
pubmed-article:2232434lifeskim:mentionsumls-concept:C2926735lld:lifeskim
pubmed-article:2232434pubmed:issue9lld:pubmed
pubmed-article:2232434pubmed:dateCreated1990-12-5lld:pubmed
pubmed-article:2232434pubmed:abstractTextWe examined the adverse reactions of the antituberculous agents in 225 hospitalized patients (150: male, 75: female, average age: 45.4 years old) and the results were summarized as follows: 1) The side effects were seen in 53 patients (23.6%), and the abnormal laboratory findings were observed in 94 patients (41.8%). 2) The incidence of adverse reactions in patients treated with three drugs (INH, RFP, EB) and four drugs (plus SM) were 45.9% and 82.4%, respectively. 3) Adverse reaction appeared within one month after starting treatment in 67.9% of eligible patients, and it disappeared within one month from its onset in 76.8% of patients. There results suggested the importance of careful clinical observation especially soon after starting antituberculous therapy.lld:pubmed
pubmed-article:2232434pubmed:languagejpnlld:pubmed
pubmed-article:2232434pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2232434pubmed:citationSubsetIMlld:pubmed
pubmed-article:2232434pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2232434pubmed:statusMEDLINElld:pubmed
pubmed-article:2232434pubmed:monthSeplld:pubmed
pubmed-article:2232434pubmed:issn0022-9776lld:pubmed
pubmed-article:2232434pubmed:authorpubmed-author:YamadaHHlld:pubmed
pubmed-article:2232434pubmed:authorpubmed-author:YamaguchiKKlld:pubmed
pubmed-article:2232434pubmed:authorpubmed-author:HaraKKlld:pubmed
pubmed-article:2232434pubmed:authorpubmed-author:KohnoSSlld:pubmed
pubmed-article:2232434pubmed:authorpubmed-author:HayashiTTlld:pubmed
pubmed-article:2232434pubmed:authorpubmed-author:HirotaMMlld:pubmed
pubmed-article:2232434pubmed:authorpubmed-author:YasuokaAAlld:pubmed
pubmed-article:2232434pubmed:authorpubmed-author:SasayamaKKlld:pubmed
pubmed-article:2232434pubmed:authorpubmed-author:DoutsuYYlld:pubmed
pubmed-article:2232434pubmed:issnTypePrintlld:pubmed
pubmed-article:2232434pubmed:volume65lld:pubmed
pubmed-article:2232434pubmed:ownerNLMlld:pubmed
pubmed-article:2232434pubmed:authorsCompleteYlld:pubmed
pubmed-article:2232434pubmed:pagination563-8lld:pubmed
pubmed-article:2232434pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2232434pubmed:meshHeadingpubmed-meshheading:2232434-...lld:pubmed
pubmed-article:2232434pubmed:meshHeadingpubmed-meshheading:2232434-...lld:pubmed
pubmed-article:2232434pubmed:meshHeadingpubmed-meshheading:2232434-...lld:pubmed
pubmed-article:2232434pubmed:meshHeadingpubmed-meshheading:2232434-...lld:pubmed
pubmed-article:2232434pubmed:meshHeadingpubmed-meshheading:2232434-...lld:pubmed
pubmed-article:2232434pubmed:meshHeadingpubmed-meshheading:2232434-...lld:pubmed
pubmed-article:2232434pubmed:meshHeadingpubmed-meshheading:2232434-...lld:pubmed
pubmed-article:2232434pubmed:meshHeadingpubmed-meshheading:2232434-...lld:pubmed
pubmed-article:2232434pubmed:meshHeadingpubmed-meshheading:2232434-...lld:pubmed
pubmed-article:2232434pubmed:meshHeadingpubmed-meshheading:2232434-...lld:pubmed
pubmed-article:2232434pubmed:meshHeadingpubmed-meshheading:2232434-...lld:pubmed
pubmed-article:2232434pubmed:year1990lld:pubmed
pubmed-article:2232434pubmed:articleTitle[Adverse reactions of antituberculous agents, especially about its onset and duration].lld:pubmed
pubmed-article:2232434pubmed:affiliation2nd Department of Internal Medicine, Nagasaki University, School of Medicine, Japan.lld:pubmed
pubmed-article:2232434pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2232434pubmed:publicationTypeEnglish Abstractlld:pubmed